» Articles » PMID: 29307557

Expression of Alternative Ago2 Isoform Associated with Loss of MicroRNA-Driven Translational Repression in Mouse Oocytes

Overview
Journal Curr Biol
Publisher Cell Press
Specialty Biology
Date 2018 Jan 9
PMID 29307557
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Mouse oocyte maturation, fertilization, and reprogramming occur in the absence of transcription, and thus, changes in mRNA levels and translation rate are regulated through post-transcriptional mechanisms [1]. Surprisingly, microRNA function, which is a major form of post-transcriptional regulation, is absent during this critical period of mammalian development [2, 3]. Here, we investigated the mechanisms underlying the global suppression of microRNA activity. In both mouse and frogs, microRNA function was active in growing oocytes but then absent during oocyte maturation. RNA sequencing (RNA-seq) of mouse oocytes uncovered that the microRNA effector protein AGO2 is predominantly expressed as an alternative isoform that encodes a truncated protein lacking all of the known essential domains. Full-length Ago2 as well as the related Argonautes (Ago1, Ago3, and Ago4) were lowly expressed in maturing mouse oocytes. Reintroduction of full-length AGO2 together with an exogenous microRNA in either mouse or frog oocytes restored translational repression of a target reporter. However, levels of endogenous transcripts remained unchanged. Consistent with a lack of microRNA activity, analysis of transcripts with alternative polyadenylation sites showed increased stability of transcripts with a longer 3' UTR during oocyte maturation. Redundant mechanisms protecting endogenous transcripts and the conserved loss of microRNA activity suggest a strong selection for suppressing microRNA function in vertebrate oocytes.

Citing Articles

Alternative cleavage and polyadenylation of the Ccnb1 mRNA defines accumulation of cyclin protein during the meiotic cell cycle.

Wang X, Leung F, Bush J, Conti M Nucleic Acids Res. 2023; 52(3):1258-1271.

PMID: 38048302 PMC: 10853788. DOI: 10.1093/nar/gkad1151.


Regulation of adult stem cell quiescence and its functions in the maintenance of tissue integrity.

de Morree A, Rando T Nat Rev Mol Cell Biol. 2023; 24(5):334-354.

PMID: 36922629 PMC: 10725182. DOI: 10.1038/s41580-022-00568-6.


Physiologically relevant miRNAs in mammalian oocytes are rare and highly abundant.

Kataruka S, Kinterova V, Horvat F, Kulmann M, Kanka J, Svoboda P EMBO Rep. 2021; 23(2):e53514.

PMID: 34866300 PMC: 8811628. DOI: 10.15252/embr.202153514.


The multifaceted roles of microRNAs in differentiation.

Galagali H, Kim J Curr Opin Cell Biol. 2020; 67:118-140.

PMID: 33152557 PMC: 8607530. DOI: 10.1016/j.ceb.2020.08.015.


MicroRNA dilution during oocyte growth disables the microRNA pathway in mammalian oocytes.

Kataruka S, Modrak M, Kinterova V, Malik R, Zeitler D, Horvat F Nucleic Acids Res. 2020; 48(14):8050-8062.

PMID: 32609824 PMC: 7430632. DOI: 10.1093/nar/gkaa543.


References
1.
Kedde M, Van Kouwenhove M, Zwart W, Vrielink J, Elkon R, Agami R . A Pumilio-induced RNA structure switch in p27-3' UTR controls miR-221 and miR-222 accessibility. Nat Cell Biol. 2010; 12(10):1014-20. DOI: 10.1038/ncb2105. View

2.
Ritchie M, Phipson B, Wu D, Hu Y, Law C, Shi W . limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43(7):e47. PMC: 4402510. DOI: 10.1093/nar/gkv007. View

3.
Su H, Trombly M, Chen J, Wang X . Essential and overlapping functions for mammalian Argonautes in microRNA silencing. Genes Dev. 2009; 23(3):304-17. PMC: 2648544. DOI: 10.1101/gad.1749809. View

4.
de Vries W, Binns L, Fancher K, Dean J, MOORE R, Kemler R . Expression of Cre recombinase in mouse oocytes: a means to study maternal effect genes. Genesis. 2000; 26(2):110-2. View

5.
Pertea M, Pertea G, Antonescu C, Chang T, Mendell J, Salzberg S . StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol. 2015; 33(3):290-5. PMC: 4643835. DOI: 10.1038/nbt.3122. View